Michael Auerbach's most recent trade in ATAI Life Sciences N.V. was a trade of 103,000 Stock Option done . Disclosure was reported to the exchange on June 13, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ATAI Life Sciences N.V. | Michael Auerbach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 103,000 | 103,000 | - | - | Stock Option | |
| ATAI Life Sciences N.V. | Michael Auerbach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 64,000 | 64,000 | - | - | Stock Option | |
| ATAI Life Sciences N.V. | Michael Auerbach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 64,000 | 64,000 | - | - | Stock Option | |
| ATAI Life Sciences N.V. | Michael Auerbach | Director | Other type of transaction at price $ 0.00 per share. | 14 Jan 2022 | 5,559,808 | 0 | - | 0 | Common Shares | |
| ATAI Life Sciences N.V. | Michael Auerbach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2021 | 128,000 | 128,000 | - | - | Stock Option | |
| ATAI Life Sciences N.V. | Michael Auerbach | Director | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 22 Jun 2021 | 4,666 | 5,564,474 | - | 15 | 69,990 | Common Shares |
| ATAI Life Sciences N.V. | Michael Auerbach | Director | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 22 Jun 2021 | 4,666 | 5,564,474 | - | 15 | 69,990 | Common Shares |